Bank Of New York Mellon Corp Celularity Inc Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.56 - $1.15 $113,234 - $232,535	202,205 New	202,205 $125 Million
Q4 2022 Feb 14, 2023	BUY	$1.08 - $2.35 $223,742 - $486,847	207,169 New	207,169 $267,000
Q3 2022 Nov 14, 2022	BUY	$0.43 - $4.31 $70,962 - $711,270	165,028 Added 632.15%	191,134 $442,000
Q2 2022 Aug 15, 2022	BUY	$2.81 - $12.91 $73,357 - $337,028	26,106 New	26,106 $89,000

23.6M

Ticker CELU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,424,000
Market Cap $319M
Description
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and BioBanking. The company's lead therapeutic programs include CYCART-19, a placental-de...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.